Elevance Health (ELV) director reports open-market sale of common stock

Rhea-AI Filing Summary

Elevance Health, Inc. director Robert L. Dixon Jr. reported an open-market sale of company stock. He sold 151 shares of common stock at a price of $401.77 per share on June 11, 2026. After this transaction, he directly holds 10,734 shares of Elevance Health common stock.

Insider Trade Summary

Net Seller: 151 shares ($60,667)

Net Sell 1 txn

Insider Dixon Robert L JR

Role null

Sold 151 shs ($61K)

Type	Security	Shares	Price	Value
Sale	Common Stock	151	$401.77	$61K

Holdings After Transaction: Common Stock — 10,734 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 151 shares Sale price: $401.77 per share Shares held after sale: 10,734 shares +1 more

4 metrics

Shares sold 151 shares Open-market sale of common stock on June 11, 2026

Sale price $401.77 per share Price for the 151-share open-market sale

Shares held after sale 10,734 shares Director’s direct holdings following the transaction

Net share change -151 shares Net-selling activity in this Form 4

Key Terms

Common Stock, open-market sale, Form 4, Sale in open market or private transaction

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Sale in open market or private transaction financial

"transaction_code_description: "Sale in open market or private transaction""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dixon Robert L JR

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		S		151	D	$401.77	10,734	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Elevance Health (ELV) disclose in this Form 4?

Elevance Health disclosed that director Robert L. Dixon Jr. executed an open-market sale of company stock. He sold 151 shares of Elevance Health common stock on June 11, 2026, as reported in the Form 4 insider trading filing.

How many Elevance Health (ELV) shares did the director sell and at what price?

Director Robert L. Dixon Jr. sold 151 shares of Elevance Health common stock. The transaction was executed at a price of $401.77 per share in an open-market sale reported for the June 11, 2026 transaction date.

How many Elevance Health (ELV) shares does the insider hold after this sale?

After the reported sale, Robert L. Dixon Jr. directly holds 10,734 shares of Elevance Health common stock. This post-transaction balance reflects his remaining direct ownership following the 151-share open-market sale on June 11, 2026.

Was the Elevance Health (ELV) insider transaction a buy or a sell?

The reported insider transaction was a sell. Director Robert L. Dixon Jr. conducted an open-market sale of 151 Elevance Health common shares, coded as an “S” transaction for sale in open market or private transaction on the Form 4.

Does the Elevance Health (ELV) Form 4 show any derivative security exercises?

No derivative security exercises are shown in this Form 4. The filing reports only a single non-derivative transaction: an open-market sale of 151 shares of Elevance Health common stock, with no option or other derivative transactions listed.